In Vitro Studies Show Veklury Retains Antiviral Activity Against SARS-CoV-2 Variants

In vitro data confirm Veklury (remdesivir) retains antiviral activity against 10 SARS-CoV-2 variants, including Delta and Omicron.

Related Keywords

Germany ,Czech Republic ,Poland ,Belgium ,Tomas Cihlar ,Gilead Sciences ,Virology Research ,Drug Administration ,Gilead Sciences Inc ,Senior Vice President ,Against Omicron ,